Product Details

Nexgard Spectra 9 mg / 2 mg Chewable Tablets for Dogs 2–3.5 kg

• MA holder: Boehringer Ingelheim Vetmedica Gmbh
• VM number: EU/2/14/177/001-003,016
• Territory: Northern Ireland
• Associated documents:
  • Available from EU Union Product Database
• Date of issue: 14/01/2015
• Authorisation route: Centralised
• Active substances:
  • Afoxolaner
  • Milbemycin Oxime (A3 and A4)
• Controlled drug: No
• Target species:
  • Dogs
• Distribution category: POM-V